Summary
We describe the development and application to clinical trials of a mathematical model of patient behaviour in acute myelogenous leukamia (AML). Observed patient behaviour in a trial can be compared with predictions made by a model derived from another set of trial data and deviations from these predictions identified and assessed. This form of analysis is applicable to trials in progress, allowing early detection of trends and differences.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
PETO, R., 1978: Clinical Trial Methodology. Biomedicine 28, 24-36.
MEIER, P., 1975: Statistics and Medical Experimentation. Biometrics 31, 511-529.
TUKEY, J.W.: Where do we go from here? Journal of the American Statistical Assocn. 55, 80-93.
GEHAN, E.A., FREIREICH, E.J., 1974: Non-Randomised Controls in Cancer Clinical Trials. The New England Journal of Medicine. 290, 198-203.
BLACK, SIR DOUGLAS: The Paradox of Medical Care. Journal of the Royal College of Physicians of London. 13, 2, 57-65.
COONBERG, L., 1979: Do retrospective controls make clinical trials “inherently fallacious?” British Medical Journal 2365-2366.
ASPDEN, P., JACKSON, R.R.P., WHITEHOUSE, J.M.A., 1976: A systems approach to the evaluation of clinical trials in a specialist oncology centre. Proc. NATO Conf. Systems Science in Health Care, Paris.
JACKSON, R.R.P., ASPDEN, P., 1979: Treatment Evaluation --A Modelling Approach with Application to Acute Myeloid Leukaemia. J. Opl. Res. Soc. Vol. 30, 1, pp 11-22.
LISTER, T.A., OLIVER, R.T.D., WHITEHOUSE, J.M.A., BELL, R., JOHNSON, S.A.N., WRIGLEY, P.F.M., FORD, J.M., CULLEN, M.H., GREGORY, W.M., PAXTON, A.M., MALPAS, J.S., Chemotherapy and Immunotherapy for Acute Myelogenous Leukaemia. Accepted by Cancer, 1979.
CROWTHER, D., POWLES, R.L., BATEMAN, C.J.T., BEARD, M.E.J., GANCI, C.K., WRIGLEY, P.F.M., MALPAS, J.S., HAMILTON FAIRLEY, G., BODLEY SCOTT, SIR RONALD, 1973: The Management of Adult Acute Myelogenous Leukaemia. British Medical Journal 20 January 1973, pp 131-137.
CROWTHER, D., BEARD. M.E.J., BATEMAN, C.J.T., SEWELL, R.L., 1975: Factors influencing prognosis in Adults with Acute Myelogenous Leukaemia. British J. Cancer, 32, 456-464.
KEATING, M.J., BODEY, G.P., McCREDIE, K.B., FREIREICH, E.J., 1979s Five Year Survival and Remission Duration in Adult Acute Myelogenous Leukaemia (AML). Proc. A.S.C.O., C-517, p 416.
MOULD, R.F., 1979: Clinical Trial Design in Cancer. Clin. Radiol. 30, 371-381.
PETO et al, 1976/77: Design & Analysis of Randomised Clinical Trials requiring Prolonged Observations of each patient. I. Introduction and design. British Journal of Cancer, 34, 585-612. Analysis and Examples, British Journal of Cancer, 35, 1-39.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Jackson, R.R.P., Moullin, L.J., Gregory, W., Bell, R., Whitehouse, J.M.A., Lister, T.A. (1980). Comparison of Clinical Trials in Acute Myelogenous Leukaemia by use of a Mathematical Model. In: Victor, N., Lehmacher, W., van Eimeren, W. (eds) Explorative Datenanalyse. Medizinische Informatik und Statistik, vol 26. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81515-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-81515-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-10281-6
Online ISBN: 978-3-642-81515-7
eBook Packages: Springer Book Archive